FinTechFunding

Noxopharm: Appoints new CEO

Noxopharm Appoints new CEO

  • Noxopharm Limited (NOX) announces a shift in leadership in preparation for an upcoming ‘growth phase’
  • Dr Gisela Mautner has been appointed as CEO starting next month, with former CEO Dr Graham Kelly remaining on the board
  • Dr Mautner joined Noxopham three years ago and oversaw the implementation of the company’s clinical programs
  • Dr Kelly will remain actively involved in Noxophar m’s future given his previous impact on the company
  • The company’s share price was up 4.9 percent to trade at 43 cents at midday AEDT
Previous article
BrainChip: Appoints Pia Turcinov as Non-Executive Director
Next article
Tyro Payments: Appoints two new board members
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...
FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...